Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Romano

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Stem Cells and Development|January 23, 2015
Molecular and phenotypic characterization of human amniotic fluid-derived cells: a morphological and proteomic approachCaterina Pipino, Laura Pierdomenico, Pamela Di Tomo, et al.
Journal of Hepatology|September 17, 2010
Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3Alessandra Mangia, Franco Bandiera, Giuseppe Montalto, et al.
World Journal of Hepatology|November 30, 2011
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphomaAdriano M Pellicelli, Massimo Marignani, Valerio Zoli, et al.
European Journal of Public Health|November 4, 2009
Patterns of chronic hepatitis B in Central Italy: a cross-sectional studyPaola Piccolo, Ilaria Lenci, Claudia Telesca, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVRAlexander J Thompson, Rosanna Santoro, Valeria Piazzolla, et al.
Acta Ophthalmologica|August 25, 2020
Factors predicting normal visual acuity following anatomically successful macular hole surgeryMatteo Fallico, Timothy L Jackson, Argyrios Chronopoulos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2009
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric studyClaudio Puoti, Adriano M Pellicelli, Mario Romano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2014
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug AgencyFloriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patientsCarlo Capirci, Vincenzo Valentini, Luca Cionini, et al.
The FEBS Journal|March 3, 2025
Inflammation and epithelial-mesenchymal transition in a CFTR-depleted human bronchial epithelial cell line revealed by proteomics and human organ-on-a-chipDomenico Mattoscio, Luis A Baeza, Haiqing Bai, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Stem Cells and Development|January 23, 2015
Molecular and phenotypic characterization of human amniotic fluid-derived cells: a morphological and proteomic approachCaterina Pipino, Laura Pierdomenico, Pamela Di Tomo, et al.
Journal of Hepatology|September 17, 2010
Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3Alessandra Mangia, Franco Bandiera, Giuseppe Montalto, et al.
World Journal of Hepatology|November 30, 2011
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphomaAdriano M Pellicelli, Massimo Marignani, Valerio Zoli, et al.
European Journal of Public Health|November 4, 2009
Patterns of chronic hepatitis B in Central Italy: a cross-sectional studyPaola Piccolo, Ilaria Lenci, Claudia Telesca, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVRAlexander J Thompson, Rosanna Santoro, Valeria Piazzolla, et al.
Acta Ophthalmologica|August 25, 2020
Factors predicting normal visual acuity following anatomically successful macular hole surgeryMatteo Fallico, Timothy L Jackson, Argyrios Chronopoulos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2009
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric studyClaudio Puoti, Adriano M Pellicelli, Mario Romano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2014
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug AgencyFloriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patientsCarlo Capirci, Vincenzo Valentini, Luca Cionini, et al.
The FEBS Journal|March 3, 2025
Inflammation and epithelial-mesenchymal transition in a CFTR-depleted human bronchial epithelial cell line revealed by proteomics and human organ-on-a-chipDomenico Mattoscio, Luis A Baeza, Haiqing Bai, et al.
Pageof 17